The Times Australia
PR Newswire

.

Microba Life Sciences appoints experienced executive Mark Capone to the Board

Microba Life Sciences appoints experienced executive Mark Capone to the Board

BRISBANE, Australia, March 18, 2021 /PRNewswire/ -- Microba Life Sciences[1] has appointed international executive, Mark Capone, as a Non-Executive Director of the Board, bringing with him more than 35 years of experience in the life sciences sector.

Mr Capone spent 17 years with Myriad Genetics, most recently as President and CEO, where he transformed a pioneering start-up into one of the largest precision medicine companies in the world.

Mr Capone led Myriad to total annual revenues of more than $800 million and steered the development and launch of more than a dozen reimbursed molecular diagnostics.

Prior to Myriad, Mr Capone had a career with Eli Lilly and Company also spanning 17 years, working throughout the entire value chain.

"I am very excited to join the board of Microba and have been impressed with the science, mission and leadership of the company," Mr Capone said.

"Diagnosing disease accurately and predicting response to therapies are still major challenges in a range of health conditions."

"Microba are at the forefront of this work, particularly in the area of the gut microbiome and I look forward to providing insights to accelerate this success."  

Microba Life Sciences CEO Blake Wills said that the company would benefit from Capone's extensive experience as it moves into the next phase of development.

"We are delighted to have Mark join our Board and are grateful for the knowledge and experience he will bring in the reimbursed diagnostics space," he said.

"Microba has microbiome-derived therapeutic[2] and diagnostic[3] programs which are progressing rapidly towards the clinic and Mark has already demonstrated his ability to add significant value."

"The commercialisation expertise and experience of Mark in the US market strongly complements the existing board and senior management of the company."

Mr Capone currently serves as President and CEO of Precision Medicine Advisors, LLC, is a non-executive board member of Abcam plc (NASDAQ:ABCM), and is a non-executive director and executive advisor for NephroSant.  

About Microba Life Sciences

Microba Life Sciences[4] is a precision microbiome science company uncovering new biology for diagnostic applications to improve patient outcomes. Powered by precision analysis, Microba's diagnostic discovery platform is harnessing the microbiome to identify medically relevant biomarkers to enable new diagnostic tools. By combining human data with advanced artificial intelligence approaches, Microba can rapidly identify microbiome signatures associated with disease diagnosis or treatment response.

www.microba.com[5]

View original content to download multimedia:http://www.prnewswire.com/news-releases/microba-life-sciences-appoints-experienced-executive-mark-capone-to-the-board-301249821.html[6]

Read more https://www.prnasia.com/story/archive/3314012_CN14012_0

Business Times

Your CEO Has More Reach Than Your Ad Budget – You’re Just Not Usi…

By Patrice Pandeleos, Managing Director of Seven Communications If your CEO hides behind a logo while competitors build infl...

From Farms to Festivals: How Regional NSW Is Repurposing Shipping…

Regional NSW communities are repurposing containers for farms, tourism, and events Farmers and small businesses use them...

Nail it with points: Flybuys members can redeem points for instan…

Flybuys launches new in-store redemption at Bunnings stores across Australia Tuesday 19 August, 2025 – Flybuys, Australia’s ...

The Times Features

How much money do you need to be happy? Here’s what the research says

Over the next decade, Elon Musk could become the world’s first trillionaire[1]. The Tesla board ...

NSW has a new fashion sector strategy – but a sustainable industry needs a federally legislated response

The New South Wales government recently announced the launch of the NSW Fashion Sector Strategy...

From Garden to Gift: Why Roses Make the Perfect Present

Think back to the last time you gave or received flowers. Chances are, roses were part of the bunch...

Do I have insomnia? 5 reasons why you might not

Even a single night of sleep trouble can feel distressing and lonely. You toss and turn, stare...

Wedding Photography Trends You Need to Know (Before You Regret Your Album)

Your wedding album should be a timeless keepsake, not something you cringe at years later. Trends ma...

Can you say no to your doctor using an AI scribe?

Doctors’ offices were once private. But increasingly, artificial intelligence (AI) scribes (al...

There’s a new vaccine for pneumococcal disease in Australia. Here’s what to know

The Australian government announced last week there’s a new vaccine[1] for pneumococcal disease ...

What Makes a Small Group Tour of Italy So Memorable?

Traveling to Italy is on almost every bucket list. From the rolling hills of Tuscany to the sparklin...

Latest data suggests Australia is overcoming its sugar addiction

Australia is now meeting the World Health Organization’s (WHO) guidelines[1] on sugar, which r...